therapies

Managing Complications of Chemotherapy Discussed on CME Webcast

by

OSUWexnerbloglogo2014 Managing Complications of Chemotherapy Discussed on CME Webcast. On this CME webcast, to update us is medical oncologist and Associate Professor of Internal Medicine from the Ohio State University and the James Cancer Hospital, Dr. Erin Bertino. And also from the James Cancer Hospital, Assistant Professor of Internal Medicine, Dr. Edmund Folefac.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the differences in toxicity for three categories of oncology therapy: cytotoxic chemotherapy, targeted therapy, and immunotherapy; and UNDERSTAND basic management of the most common toxicities of chemotherapy, targeted therapy, and immunotherapy.

You’ll also learn about the following:

  • Evolution of targeted therapies and immunotherapy
  • What to expect with cancer treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Therapies for Type 2 Diabetes

by

OSUWexnerbloglogo2014 Learn About New Therapies for Type 2 Diabetes. 25 years ago, the management of type II diabetes was easy. You started a patient on a sulfonylurea and then if their glucose level didn’t improve, you added in NPH insulin. But things have changed. And today, we have better and safer medications to treat diabetes. Which is a good thing because the prevalence of diabetes over the past 25 years has grown enormously and we really needed new treatments to fight against this public health threat. But with new treatments can come confusion about which to use in different clinical situations. Joining our moderator on this CME webcast, to update us on the management of type 2 diabetes is endocrinologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Joshua Joseph.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the role of new medical therapies in hypoglycemia; and DESCRIBE the role of new medical therapies in cardiovascular disease.

You’ll also learn about the following:

  • New directions in the treatment of type 2 diabetes
  • Hemoglobin A1C targets
  • Treatment of type 2 diabetes when medication cost is a consideration
  • New glucose monitoring technologies

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses New Therapies for Lung Cancer

by

OSUWexnerbloglogo2014 CME Webcast Discusses New Therapies for Lung Cancer. On this CME webcast, we’re going to update you on the medical management of lung cancer and focus on non-small cell lung cancer. Joining our moderator in the studio is medical oncologist at the James Cancer Hospital and Professor of Internal Medicine from the Ohio State University, Dr. David Carbone.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review some of the latest practice-changing findings in the management of lung cancer; and Understand the basic principles of workup and initial lung cancer management decisions.

You’ll also learn about the following:

  • Classifying non-small cell lung cancer
  • Common side effects of driver-targeted therapies
  • What the primary care physician needs to know about co-managing patients taking driver-targeted therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

 

Learn About Approach to Cough on CME Webcast

by

OSUWexnerbloglogo2014 Learn About Approach to Cough on CME Webcast. A chronic cough can affect a patient’s quality of life and can be frightening to patients who are worried that it could be a symptom of a life-threatening disease. Joining our moderator in the studio to tell us about the causes and clinical approach to acute and chronic cough are two pulmonologists from the Ohio State University. We have Dr. Vincent Esguerra who is an Assistant Professor of Internal Medicine and Dr. Carleen Risaliti who is also an Assistant Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY the most common causes of chronic cough and recognize associated signs/symptoms; APPLY an appropriate diagnostic and treatment algorithm to patients with chronic cough; DESCRIBE the general mechanism of the cough reflex; and UNDERSTAND the distinction between acute, sub-acute, and chronic cough.

You’ll also learn about the following:

  • Role of the chest x-ray in evaluation of cough
  • Opioid cough suppressants
  • Cough suppression therapies

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Drugs for Lipid Management

by

OSUWexnerbloglogo2014 Learn About New Drugs for Lipid Management. Managing hyperlipidemia used to be so easy. If a patient’s total cholesterol was greater than 200, then we started them on lovastatin to reduce it. But things are a lot more complicated now. There isn’t a single cholesterol target for all patients and we have gone way beyond statins as the only game in town for cholesterol management. On this CME webcast, we’re going to update you on the newest developments in lipid management. What tests to order, who to treat and which drugs to use. Joining our moderator in the studio is cardiologist and Associate Professor of Internal Medicine, Dr. John Larry and pharmacist and Assistant Professor of Pharmacy, Melissa Snider.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW updates in approaches to treatment of dyslipidemia; DISCUSS recent evidence for non-statin lipid lowering therapies; DISCUSS place in therapy of available lipid lowering therapies; and REVIEW clinical approach to statin intolerance.

You’ll also learn about the following:

  • Patient-specific cholesterol targets
  • Multidisciplinary lipid clinics at the OSU Wexner Medical Center
  • The expanding role of pharmacists in outpatient clinical practice
  • Diet and cholesterol

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.